Get the latest Science News and Discoveries
New insights could unlock immunotherapy for rare, deadly eye cancer - EurekAlert
New research from the University of Pittsburgh explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy, which involves growing a patient’s T cells outside the body before reinfusing them, can successfully treat this rare and aggressive cancer.
None
Or read this on Eureka Alert